hydroxychloroquine has been researched along with Lipodystrophy, Intestinal in 12 studies
Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In this case, cardiotoxicity is the consequence of the lysosomal dysfunction and the result of intracytoplasmic granular material inclusions." | 5.43 | [Early cardiotoxicity of Hydroxychloroquine]. ( Duhaut, P; Guillaumont, MP; Schmidt, J; Touati, G; Zerbib, Y, 2016) |
| "In this case, cardiotoxicity is the consequence of the lysosomal dysfunction and the result of intracytoplasmic granular material inclusions." | 1.43 | [Early cardiotoxicity of Hydroxychloroquine]. ( Duhaut, P; Guillaumont, MP; Schmidt, J; Touati, G; Zerbib, Y, 2016) |
| "Immune reconstitution inflammatory syndrome is a rare complication of the treatment of Whipple's disease." | 1.42 | Immune reconstitution inflammatory syndrome during treatment of Whipple's disease. ( D'Incan, M; Dubost, JJ; Soubrier, M; Tournadre, A; Vayssade, M, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 11 (91.67) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Sanchez, A | 1 |
| Del Giudice, P | 1 |
| Mantion, C | 1 |
| Mazellier, S | 1 |
| Boukari, F | 1 |
| Roger, PM | 1 |
| Courjon, J | 1 |
| Armstrong, N | 1 |
| Richez, M | 1 |
| Raoult, D | 5 |
| Chabriere, E | 1 |
| Le Goff, M | 1 |
| Cornec, D | 1 |
| Guellec, D | 1 |
| Marhadour, T | 1 |
| Devauchelle-Pensec, V | 1 |
| Jousse-Joulin, S | 1 |
| Herbette, M | 1 |
| Cauvin, JM | 1 |
| Le Guillou, C | 1 |
| Renaudineau, Y | 1 |
| Jamin, C | 1 |
| Pers, JO | 1 |
| Saraux, A | 2 |
| Lagier, JC | 4 |
| Fenollar, F | 1 |
| Lepidi, H | 1 |
| Giorgi, R | 1 |
| Million, M | 1 |
| Lochouarn, M | 1 |
| Pulcini, C | 1 |
| Emonet, S | 1 |
| Wuillemin, T | 1 |
| Harbarth, S | 1 |
| Wassilew, N | 1 |
| Cikirikcioglu, M | 1 |
| Schrenzel, J | 1 |
| van Delden, C | 1 |
| Vayssade, M | 1 |
| Tournadre, A | 1 |
| D'Incan, M | 1 |
| Soubrier, M | 1 |
| Dubost, JJ | 1 |
| Zerbib, Y | 1 |
| Guillaumont, MP | 1 |
| Touati, G | 1 |
| Duhaut, P | 1 |
| Schmidt, J | 1 |
| Gruber, JR | 1 |
| Sarro, R | 1 |
| Delaloye, J | 1 |
| Surmely, JF | 1 |
| Siniscalchi, G | 1 |
| Tozzi, P | 1 |
| Jaques, C | 1 |
| Jaton, K | 1 |
| Delabays, A | 1 |
| Greub, G | 1 |
| Rutz, T | 1 |
| Cammilleri, S | 1 |
| Hoppé, E | 1 |
| Masson, C | 1 |
| Audran, M | 1 |
| Drillon, M | 1 |
| Andreu, M | 1 |
| Berthelot, JM | 1 |
| Maugars, Y | 1 |
| Hmamouchi, I | 1 |
| Morel, J | 1 |
| Ansemant, T | 1 |
| Celard, M | 1 |
| Tavernier, C | 1 |
| Maillefert, JF | 1 |
| Delahaye, F | 1 |
| Ornetti, P | 1 |
12 other studies available for hydroxychloroquine and Lipodystrophy, Intestinal
| Article | Year |
|---|---|
Erythematous skin nodules during treatment of Whipple's disease.
Topics: Biopsy; Doxycycline; Glucocorticoids; Humans; Hydroxychloroquine; Immune Reconstitution Inflammatory | 2021 |
Simultaneous UHPLC-UV analysis of hydroxychloroquine, minocycline and doxycycline from serum samples for the therapeutic drug monitoring of Q fever and Whipple's disease.
Topics: Anti-Bacterial Agents; Chromatography, High Pressure Liquid; Doxycycline; Drug Monitoring; Drug Stab | 2017 |
Peripheral-blood b-cell subset disturbances in inflammatory joint diseases induced by Tropheryma whipplei.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; B-Lymphocyte Subsets; Ceftriaxone | 2019 |
Treatment of classic Whipple's disease: from in vitro results to clinical outcome.
Topics: Adult; Aged; Anti-Bacterial Agents; Doxycycline; Drug Monitoring; Drug Therapy, Combination; Female; | 2014 |
A case of Whipple's disease evolving over 30 years.
Topics: Anti-Bacterial Agents; Antibodies, Bacterial; Aortic Valve Insufficiency; Biopsy; Disease Progressio | 2014 |
Relapse of Tropheryma whipplei endocarditis treated by trimethoprim/sulfamethoxazole, cured by hydroxychloroquine plus doxycycline.
Topics: Anti-Bacterial Agents; Aortic Valve; Ceftriaxone; Doxycycline; Drug Therapy, Combination; Endocardit | 2015 |
Immune reconstitution inflammatory syndrome during treatment of Whipple's disease.
Topics: Adrenal Cortex Hormones; Aged; Anti-Infective Agents; Doxycycline; Humans; Hydroxychloroquine; Immun | 2015 |
[Early cardiotoxicity of Hydroxychloroquine].
Topics: Aged; Antimalarials; Cardiotoxicity; Endocarditis, Bacterial; Female; Humans; Hydroxychloroquine; Wh | 2016 |
Tropheryma whipplei bivalvular endocarditis and polyarthralgia: a case report.
Topics: Aged; Anti-Bacterial Agents; Aortic Valve; Arthralgia; Doxycycline; Echocardiography; Endocarditis, | 2015 |
Classic Whipple's disease diagnosed by (18)F-fluorodeoxyglucose PET.
Topics: Doxycycline; Endocarditis, Bacterial; Fluorodeoxyglucose F18; Humans; Hydroxychloroquine; Male; Midd | 2016 |
Whipple's disease diagnosed during biological treatment for joint disease.
Topics: Adalimumab; Adult; Aged; Anti-Bacterial Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Huma | 2010 |
Whipple's disease endocarditis following anti-TNF therapy for atypical rheumatoid arthritis.
Topics: Anti-Bacterial Agents; Antirheumatic Agents; Arthritis, Rheumatoid; Biopsy; Diagnosis, Differential; | 2010 |